Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03259646 · ClinicalTrials.gov registry record · NA

The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
6,272
Enrollment target

NCT03259646: Completed NA study, sponsored by Johns Hopkins University.

NCT03259646 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 6,272 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (347% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03259646, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
6,272 participants
Enrollment target

Study Summary

Violence against women is a major public health threat that carries significant consequences for women's health. Moreover, women experiencing intimate partner violence (IPV) and sexual assault (SA) are more likely than non-abused women to seek certain forms of health services, such as for sexually transmitted infections, chronic pain and illnesses, depression and/or pregnancy-related concerns. As a result, the health sector is an ideal setting to identify and support survivors. The U.S. Institute of Medicine has identified the health care system, including the public health infrastructure, as key for identification of and support for survivors of violence, as well as for violence prevention. While some evidence-based models exist, no current national consensus has been reached on scalable best practices in screening and brief counseling for IPV/SA. This multi-level intervention includes integrating into the clinic setting IPV/SA screening, universal education, trauma informed counseling, warm referrals (e.g. provider/staff contact advocacy program with survivor) to local IPV/SA advocacy agencies, and access to the evidence-based myPlan safety decision aid app. The evaluation, using a cluster randomized trial design, will measure longitudinal outcomes (over 6 months) of patient self-efficacy, health and safety outcomes, as well as participant and provider perceptions of the intervention and clinic level changes in primary and reproductive health clinics in four states (Arizona, Massachusetts, Pennsylvania and West Virginia) to achieve the following aims: Aim 1. Evaluate the effectiveness of an evidence-based screening, universal education and trauma-informed counseling with tailored safety action plan and referrals to partner IPV/SA programs compared to standard practice, on survivor health and safety outcomes over a cumulative period of six months. Aim 2. Examine longitudinal changes in clinic-level screening, universal education, trauma informed counseling, safe

Primary Outcome

Measured by percent of safety behaviors the woman has tried and found helpful on the Safety Behaviors Checklist. The checklist was adapted from Sullivan and colleagues and Parker and colleagues. Includes use of community resources and safety steps (e.g. asked for help, hidden emergency money) and use of formal services (e.g., women's shelter, protection order, mental health services).

Interventions

  • BEHAVIORAL Universal Education

Trial Details

FieldValue
Enrollment Target 6,272 participants
Start Date 2017-05-26
Est. Completion 2019-04-25
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT03259646 record still lists

NCT03259646 is an interventional study that assigns participants to a tested intervention. Its 6,272 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (347% higher).

The record links to 0 conditions, and to 1 intervention - of which Universal Education is the first listed.

NCT03259646 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03259646 about?

NCT03259646 is a clinical study titled "The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women". Violence against women is a major public health threat that carries significant consequences for women's health. Moreover, women experiencing intimate partner violence (IPV) and sexual assault (SA) are more likely than non-abused women to seek certain forms of health services, such as for sexually t...

What is the current status of trial NCT03259646?

This trial is currently completed. It is a NA study. The enrollment target is 6,272 participants. The study started on 2017-05-26. Estimated completion is 2019-04-25.

What interventions are being tested in trial NCT03259646?

The interventions under investigation include: Universal Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT03259646?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03259646's enrollment target sits among peer trials

6,272 21st of 2000 higher than 1,980 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04884802 · 6,254 participants · NA

    The GUARDIAN Trial

  • NCT03960099 · 6,250 participants · NA

    Pictographs for Preventing Wrong-Patient Errors in NICUs

  • NCT05440851 · 6,250 participants · NA

    Platform of Randomized Adaptive Clinical Trials in Critical Illness

  • NCT06566170 · 6,250 participants

    A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03259646, the US trial registry maintained by the National Library of Medicine. NCT03259646 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.